 |
|||
 |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
|
|||||||||||||||||
|
|||||||||||||||||
|
|
||||||||||||||||
|
Executive Committee: Several members of the management team are the original founders
of Isis Pharmaceuticals, Inc. Together, the executive committee
has nearly a century of experience in advancing RNA-based technologies.
The committee's collective industry experience, vision and dedication
to RNA-based drug discovery and development, combined with your
support, have made Isis a leader. Stanley T. Crooke, M.D., Ph.D. B. Lynne Parshall, J.D. Jeffrey M. Jonas, M .D. C. Frank Bennett, Ph.D. David J. Ecker,
Ph.D. Michael J. Treble |
|
|
 |
|